h
PSC
reg
®
Home
Browse
All cell lines
All hiPSC lines
All hESC lines
Cell line providers
Research projects
Countries
Diseases
Publications
Clinical studies
Info
About hPSCreg
FAQ
Cell Registration
Glossary
Documents & Governance
Fact Sheets
Naming Tool
Publishing your line
Structures
Registration Summary
Certification
Organoids
API
Export Data
SPARQL Guide
Contact
News
Newsletter Subscription
Privacy Policy
Terms of Use
Imprint
Login
Log-in
Sign up
Forgot your password?
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our
Privacy Policy
for details.
This website uses cookies,
learn more
x
UJSi002-A
Registration Summary
:
A
P
E
C
The cell line is
not submitted
yet.
(only basic data is shown)
General
Cell Line
hPSCreg name
UJSi002-A
Cite as:
When citing this cell line, please use the hPSCreg name (see
Naming Tool
) and the corresponding Research Resource ID (RRID).
UJSi002-A (RRID:CVCL_B7MD)
Cell line type
Human induced pluripotent stem cell (hiPSC)
Similar lines
No similar lines found.
Last update
31st March 2022
User feedback
show/hide
Written by
on
Delete
No feedback available yet.
Login
to share your feedback, experiences or results with the research community.
Provider
Generator
Jiangsu University (UJS)
Contact:
Jiangsu University (UJS)
External Databases
BioSamples
SAMEA13061466
Cellosaurus
CVCL_B7MD
Wikidata
Q112930512
General Information
Publications
Sun J et al. Generation of ultra-treatment-resistant schizophrenia patient-derived induced pluripotent stem cell line UJSi002-A. Stem cell research. 2022 May;61:102766.
Chen Yuzhuo et al. Proanthocyanidins inhibited colorectal cancer stem cell characteristics through Wnt/β‐catenin signaling. Environmental Toxicology. 2023-12-00.
Sun T et al. Generation of hereditary spastic paraplegia patient-derived induced pluripotent stem cell line UJSi003-A. Stem cell research. 2024 Dec;81:103535.
Xi S et al. Generation of patient-derived induced pluripotent stem cell line UJSi004-A from ultra-treatment-resistant schizophrenia. Stem cell research. 2024 Dec;81:103575.
* Is the cell line readily obtainable for third parties?
Yes
Clinical use:
allowed
Commercial use:
not allowed
hIPSC Derivation
General
Login to share your feedback, experiences or results with the research community.